Abstract
Rhenium(i) complexes modified with a tetrazine carbamate group were designed as bioorthogonally dissociative photosensitisers for the controlled induction of immunogenic cell death (ICD) after treatment with trans-cyclooct-4-enol and light.
Funding Information
  • Innovation and Technology Commission

This publication has 48 references indexed in Scilit: